Avastin May Help Treat Ovarian Cancer
Study Shows Avastin May Reduce the Risk of Cancer Progression in Ovarian Cancer Patients
WebMD News Archive
Avastin Side Effects continued...
For now, "each woman and her doctor will have to decide whether coming in for an IV infusion every three weeks, for an additional four months, is worth" a four-month gain in terms of stalling cancer progression, she says.
Burger notes that women who received chemotherapy prior to surgery for advanced ovarian cancer weren't included in the study. "We haven't established its safety for such patients yet," he says.
Although Avastin isn't approved for ovarian cancer, doctors can prescribe it "off-label," Burger says. When used for approved cancers, it generally costs several thousand dollars a month.
A spokesperson for Genentech, maker of the drug, says the company hopes to use the study results to seek FDA approval for use in ovarian cancer.
About 22,000 new cases of ovarian cancer will be diagnosed this year, and about 15,000 women will die from the disease, according to the American Cancer Society.
This study was presented at a medical conference. The findings should be considered preliminary as they have not yet undergone the "peer review" process, in which outside experts scrutinize the data prior to publication in a medical journal.